Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 7,480.00
-690.00 (-8.45%)
At close: Mar 9, 2026
Keeps Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 150,185 | 97,681 | 119,991 | 127,866 | 235,610 | 309,093 | Upgrade
|
| Market Cap Growth | 9.73% | -18.59% | -6.16% | -45.73% | -23.77% | 428.37% | Upgrade
|
| Enterprise Value | 196,177 | 122,355 | 160,512 | 124,281 | 215,414 | 294,582 | Upgrade
|
| Last Close Price | 7480.00 | 5210.00 | 6400.00 | 6820.00 | 13100.00 | 20150.00 | Upgrade
|
| PE Ratio | - | 87.73 | 30.53 | - | - | - | Upgrade
|
| Forward PE | - | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | Upgrade
|
| PS Ratio | 0.95 | 0.77 | 1.30 | 8.75 | 55.30 | 20.31 | Upgrade
|
| PB Ratio | 1.67 | 1.55 | 2.05 | 2.45 | 3.87 | 6.07 | Upgrade
|
| P/TBV Ratio | 5.27 | 8.76 | 4.50 | 2.45 | 3.92 | 6.28 | Upgrade
|
| P/OCF Ratio | - | 20.31 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.24 | 0.96 | 1.74 | 8.50 | 50.56 | 19.36 | Upgrade
|
| EV/EBITDA Ratio | - | 13.89 | 35.65 | - | - | 1355.37 | Upgrade
|
| EV/EBIT Ratio | - | 19.65 | 52.45 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.79 | 0.88 | 0.83 | 0.55 | 0.45 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | 29.15 | 6.33 | 10.73 | - | - | 95.42 | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.52 | 0.64 | 0.07 | -0.22 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 12.96 | 3.72 | 8.31 | -0.46 | 1.16 | -50.45 | Upgrade
|
| Net Debt / FCF Ratio | -2.03 | -18.32 | -35.68 | -3.76 | 1.57 | 3.94 | Upgrade
|
| Asset Turnover | 0.88 | 0.90 | 0.91 | 0.16 | 0.05 | 0.26 | Upgrade
|
| Inventory Turnover | 7.19 | 8.57 | 22.90 | 7.05 | 4.01 | 6.10 | Upgrade
|
| Quick Ratio | 0.80 | 0.47 | 0.40 | 0.99 | 1.59 | 1.67 | Upgrade
|
| Current Ratio | 1.55 | 0.83 | 0.84 | 1.35 | 2.10 | 2.29 | Upgrade
|
| Return on Equity (ROE) | 0.30% | 2.65% | 6.25% | -21.28% | -29.03% | -6.27% | Upgrade
|
| Return on Assets (ROA) | -0.26% | 2.76% | 1.89% | -6.23% | -9.03% | -0.42% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.64% | 3.10% | 2.60% | -17.23% | -28.11% | -1.21% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.50% | 7.80% | 5.00% | -16.70% | -19.50% | -0.70% | Upgrade
|
| Earnings Yield | -0.02% | 1.14% | 3.28% | -8.90% | -6.50% | -0.78% | Upgrade
|
| FCF Yield | -10.39% | -1.83% | -0.87% | -0.75% | -3.60% | -0.90% | Upgrade
|
| Buyback Yield / Dilution | -2.50% | -0.38% | -0.40% | -8.22% | -18.22% | -14.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.